Thursday, January 29, 2015

Observation and Question of the Day January 29, 2015 I hear from some readers that price or cost of compounded drugs does matter to them and how much compounders are pocketing as profit doesn't matter. They prefer a cheaper made compounded drug to a more expensive commercially available drug. While price is not suppose to be factor, it clearly has become a factor. So how many consumers of compounded drugs price shop their compounds?

In other words, do you call more than one compounding pharmacy to see who can make the compound the cheapest? Why wouldn't you especially if the stories are true about adding APIs to jack up the prices? Why wouldn't you when you learn that if the same compound is sold for office use to your doctor it is way cheaper than if it is sold directly to you? Why wouldn't you if you are having to pay for it yourself rather than your insurance paying for it?  What are the potential consequences to consumers and to compounders if we openly make price a factor and tell consumers to shop around for who can make the cheapest version of the compound? Will the compounders who do the proper procedures, test, etc. and have the lowest profit margins be driven out of the market by those who don't use proper procedures, don't test, don't follow the regulations etc.?  Isn't that happening right now?  Many advertise their price on the Internet so consumers can easily price shop now.  If we openly say price is a factor and that is okay, would it cause price wars that result in a level playing field?  Do a search on the Internet to see how many compounding pharmacies you can find that will make whatever compound you want?  Do a search to see how many advertise their price? As consumers we may not know however we aren't comparing apples to apples. We may not know that one company  follows the rules and regulations and test and one doesn't and that is why the price is different. And maybe consumers don't care too much about whether rules and regulations are followed anymore.  Maybe they don't care where the API/bulk powders come from (because my guess is you can make a cheaper compounded drug if you buy from less reputable sources of powders).  Maybe all consumers care about in 2015 is if the compounded drug works for them or at least they believe that it does and that the price is the lowest possible. 

EMA Touts Big Year for Veterinary Products By Michael Mezher - Published 27 January 2015

EMA Touts Big Year for Veterinary Products
The European Medicines Agency (EMA) recommended 20 new veterinary medicines for approval in 2014, the highest number in the past five years, according to data provided by the regulator. The agency also boasts that it received 29 requests for classification of medicines intended for rare diseases or species with a small population, the most the agency has seen in a single year.
- See more at: http://www.raps.org/focus-online/news.aspx#sthash.0y58pURt.dpuf

How to Effectively Respond to FDA 483s

  1. How to Effectively Respond to FDA 483s

    Medical Device and Diagnostics Industry (blog)-18 hours ago
    In 2014, FDA conducted 527 medical device compliance inspections in the United States, almost half of which resulted in the issuance of an FDA Form 483.

State prisons submit execution secrecy rule

  1. State prisons submit execution secrecy rule

    Columbus Dispatch (blog)-19 hours ago
    It shields certain companies, primarily "compounding pharmacies," and individuals involved in the execution process from public disclosure. The secrecy ...

IACP Launches New Publications

IACP Launches New Publications! - International Academy ...

www.iacprx.org/news/213330/IACP-Launches-New-Publications.htm
20 hours ago - IACP is proud to announce the launch of its two new publications,Compounding Matters Quarterly and Pharmacy Marketing Quarterly! Our inaugural issue of .

Wednesday, January 28, 2015

LA Register December 2014 - Pharmacy Compounding & Dispenser Reporting to PMP - Louisiana Pharmacists Association

LA Register December 2014 - Pharmacy Compounding & Dispenser Reporting to PMP - Louisiana Pharmacists Association

Oklahoma Board of Pharmacy New Rules Approved on January 14, 2015 and submitted to the legislature for approval

California Board of Pharmacy Agenda and Materials for Meeting January 27-28, 2015

January 27-28, 2015
Webcast
Department of Consumer Affairs
1625 N. Market Blvd.
1st Floor Hearing Room
Sacramento, CA 95834
AgendaMeeting Materials

List of FDA 483 Issued and Released for Compounding Pharmacies in 2014

FDA 483 Total Pharmacy Services, Inc., Houma, LA Issued 9/30/2014